Display options
Share it on

Pathogens. 2021 Jun 29;10(7). doi: 10.3390/pathogens10070814.

Modulation of Splenic B Cell Subsets during Experimental .

Pathogens (Basel, Switzerland)

Koushik Mondal, Shantanabha Das, Khudiram Naskar, Syamal Roy

Affiliations

  1. CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.
  2. Department of Ophthalmology, Hamilton Eye Institute, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  3. Department of Zoology, Diamond Harbour Women's University, Sarisha, South 24 Parganas, West Bengal 743368, India.

PMID: 34209841 PMCID: PMC8308600 DOI: 10.3390/pathogens10070814

Abstract

Sodium antimonials are one of the major and common drugs used against visceral form leishmaniasis (VL). However, the development of drug resistance makes it difficult to manage this disease. Current work investigates the modulation of splenic B cells during experimental infection with antimony-sensitive and -resistant

Keywords: B1a B cell; Follicular B cell; Transitional B cell; antimony resistance; cytokines; visceral leishmaniasis

References

  1. Infect Immun. 1990 Dec;58(12):3893-8 - PubMed
  2. Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):E575-82 - PubMed
  3. J Immunol. 2001 Dec 15;167(12):6834-40 - PubMed
  4. Clin Exp Immunol. 1989 May;76(2):190-7 - PubMed
  5. J Exp Med. 1999 Jul 5;190(1):75-89 - PubMed
  6. Parasitology. 2015 Oct;142(12):1506-15 - PubMed
  7. Front Microbiol. 2018 Dec 21;9:3056 - PubMed
  8. Eur J Immunol. 2010 May;40(5):1355-68 - PubMed
  9. Sci Transl Med. 2013 Sep 11;5(202):202ra121 - PubMed
  10. Immunol Rev. 2014 May;259(1):259-72 - PubMed
  11. J Transl Med. 2020 Mar 17;18(1):131 - PubMed
  12. Scand J Immunol. 2000 May;51(5):533-41 - PubMed
  13. Int Immunol. 2005 Apr;17(4):373-82 - PubMed
  14. J Immunol. 2014 Feb 1;192(3):919-28 - PubMed
  15. Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):E823-32 - PubMed
  16. Front Cell Infect Microbiol. 2019 Mar 01;9:30 - PubMed
  17. J Infect Dis. 1999 Aug;180(2):564-7 - PubMed
  18. J Immunol. 2004 Nov 15;173(10):6346-56 - PubMed
  19. Nat Rev Immunol. 2011 Jan;11(1):34-46 - PubMed
  20. Immunol Rev. 2004 Oct;201:239-53 - PubMed
  21. J Immunol. 2007 Jun 15;178(12):7511-5 - PubMed
  22. J Immunol. 2010 Jan 15;184(2):886-94 - PubMed
  23. Immunity. 1995 Nov;3(5):549-60 - PubMed
  24. J Invest Dermatol. 2009 Feb;129(2):266-77 - PubMed
  25. J Immunol. 1984 Apr;132(4):2072-7 - PubMed
  26. Cytokine. 2021 Sep;145:155245 - PubMed
  27. PLoS Negl Trop Dis. 2014 Jul 17;8(7):e2995 - PubMed
  28. J Immunol. 2014 Oct 15;193(8):4083-94 - PubMed
  29. Front Immunol. 2019 Jan 04;9:3015 - PubMed
  30. Cell. 2019 Apr 18;177(3):524-540 - PubMed
  31. Front Immunol. 2019 Apr 05;10:670 - PubMed
  32. Front Immunol. 2014 Oct 31;5:535 - PubMed
  33. Arthritis Rheum. 2009 Jul;60(7):1873-80 - PubMed
  34. Clin Microbiol Rev. 2006 Jan;19(1):111-26 - PubMed
  35. Cell Rep. 2016 Jun 14;15(11):2427-37 - PubMed
  36. Int Immunol. 2002 Feb;14(2):157-66 - PubMed
  37. Clin Immunol. 2006 Jun;119(3):339-45 - PubMed
  38. J Immunol. 2012 Apr 15;188(8):3961-71 - PubMed
  39. Int J Parasitol. 2011 Nov;41(13-14):1311-21 - PubMed
  40. J Cell Sci. 2016 Aug 15;129(16):3130-43 - PubMed
  41. J Exp Med. 2012 May 7;209(5):1001-10 - PubMed
  42. Infect Immun. 2008 Sep;76(9):4088-91 - PubMed
  43. PLoS Negl Trop Dis. 2015 Feb 24;9(2):e0003543 - PubMed
  44. Front Microbiol. 2017 Jun 02;8:978 - PubMed
  45. J Immunol. 2000 Apr 1;164(7):3681-8 - PubMed
  46. J Immunol. 2016 May 15;196(10):4100-9 - PubMed

Publication Types

Grant support